Özet

青光眼眼中的超声环成形术

Published: January 26, 2018
doi:

Özet

青光眼是一种慢性疾病, 逐渐退化的视神经纤维, 导致视野下降。眼压升高被认为是最重要和唯一可治疗的危险因素。这份手稿描述了一个简单的, 外科手术友好, 非切口技术, 命名为超声环成形术, 以减少眼压在青光眼患者。

Abstract

青光眼是一种慢性疾病, 由光学神经纤维的渐进变性引起, 导致视力下降, 导致视力严重受损, 最终失明。这份手稿描述了一个简单的, 外科手术友好, 非切口技术, 命名为超声环成形术 (解偶), 以减少眼压 (眼压) 的青光眼患者。该技术决定了睫状体的选择性凝固坏死;此外, 最近还提出了 uveo-巩膜流出通路的超脉络膜和反巩膜部分的刺激。与以前的技术相比, 在超声技术方面有了一些技术上的改进, 为目标区域提供了更精确的聚焦。手术在手术室进行球麻醉。简单地说, 耦合锥是与眼睛和环探头, 其中包含六压电传感器, 产生超声束, 在它里面插入。他们正确的中心在眼表面代表了一个关键的步骤, 正确的靶向睫状体。用无菌平衡盐溶液填充空腔, 保证超声声传播。外科治疗包括在每一个六传感器的顺序自动激活, 总持续时间少于3分钟。病人在手术后离开医院1小时, 用治疗过的眼睛修补。在本研究中, 10 例开角型青光眼患者在术后至少12月内随访。与手术前相比, 每隔一段时间, 眼压降低, 低血压药物的数量也减少。20% 的患者对治疗没有反应, 需要随后的手术来更好地控制眼压。治疗耐受性好, 无眼压或肺结核。与传统的 cyclodestructive 程序相比, 这种方法更简单、更快、更安全、更少侵入, 从而减少眼压。

Introduction

青光眼是导致全世界失明的主要原因之一, 影响约1亿人的1。它是由神经纤维的渐进变性所产生的一种光学神经病, 它会聚在视神经上, 从而在视觉上减少了视力障碍, 最终导致失明而没有足够治疗2

高眼压仍然被认为是青光眼发病和进展的主要危险因素, 目前唯一可以治疗的参数是减少视觉领域的损失3。通过使用局部或全身药物、激光或外科手术3,4, 可以通过减少水幽默的产生和/或通过小梁网增加其流出来达到眼压降低。在加热或冷冻后, 已经引入了许多物理过程来诱导睫状体的凝固坏死5,6,7,89, 101112。然而, 缺乏选择性的目标组织和不可预知的剂量效应关系, 减少眼压限制他们只使用的眼睛与青光眼的常规医疗和外科治疗4

在过去的几年中, 一个新的装置, 名为 “统一”, 使用高强度聚焦超声 (HIFU) 已经开发, 目的是克服传统的 cyclodestructive 技术的局限性, 实现更有选择性的凝聚睫状体和避免可能损害相邻眼部结构13,14,15,16,17,18,19,20,21. 此外, 最近还提出了 uveo-巩膜流出通路的超脉络膜和反巩膜部分的刺激, 作为减少眼压的一个可能的辅助机制.迄今为止, 在不同类型和严重程度的青光眼中进行了七项主要临床研究, 证明了这种非切口手术的有效性和安全性14,15, 19,20,21,22,23,24

本研究的目的是详细描述上述程序, 以便将其介绍的知识传播给科学医学界, 并为想接近这一新领域的外科医生提供有用的技巧和技巧。

Protocol

所有参加者在任何研究程序之前都提供口头和书面的同意。该项研究的议定书是按照《赫尔辛基宣言》进行的, 并得到了桑特·乌苏拉-Malpighi 教学医院人类研究道德委员会的批准。 1. 术前程序和眼科评价 测试距离和接近最佳矫正视力 (BCVA)。 用狭缝灯显微镜评价眼前段。 在注入了局部麻醉眼药水后, 用狭缝灯前房透镜检查前房角。 用非接触眼底?…

Representative Results

根据上述技术, 对开放角型青光眼患者10例 (6 男性和4女性, 平均年龄64.9 ±13.7 岁, 范围39–80岁) 十眼进行治疗。治疗暴露时间为2例, 6 例为4例, 8 患者为4秒。术前平均眼压为24.8 ±9.6 柱 (平均±标准差), 每日低血压下降值为3.9 ± 1.0, 每日胺片平均数为0.6 ±0.5。另外, 平均视力为 0.48 logMAR ± 0.6, 平均视场平均偏差为-12.65 ± 12.1 dB。 八?…

Discussion

青光眼是一种慢性渐进性疾病, 影响视神经, 需要新的有效治疗来改善远期预后。眼压的减少仍然被认为是唯一有效的治疗方法, 以防止或延迟视力领域的损失, 在眼睛和没有高眼压3

是一种新的非切口 cyclodestructive 术, 可以降低眼压, 采取两种不同的方式: 减少水中的体液流入, 确定睫状体分泌上皮的选择性坏死, 增加水的幽默感。uveo-巩膜流出刺激跨巩膜和?…

Açıklamalar

The authors have nothing to disclose.

Acknowledgements

作者没有致谢声明。

Materials

BM 900 Slit Lamp Biomioscropy Haag-Streit, Koeniz, Switzerland BM 900 Slit Lamp Biomiscroscopy
G-4 Four-Mirror Glass Gonio Lens Volk Optical Inc., Mentor, OH, USA #VG4 Contact lens for gonioscopy
78D Non Contact Slit Lamp Lens Volk Optical Inc., Mentor, OH, USA #V78C Non contact slit lamp lens
HospiFluo strips AIESI Hospital Service S.a.s., Napoli, Italy AHS129 Fluorescein sterile disposable strips
AT 900 Goldmann Applanation Tonometer Haag-Streit, Koeniz, Switzerland AT 900 Goldmann applanation tonometer
Lenstar LS900 Haag-Streit, Koeniz, Switzerland LS900 Optical biometer
Pilocarpina 2% eye drops Farmigea, Pisa, Italy S01EB01 Miotic eye drops
Mepivacaina 20mg/ml injectable solution Angelini, Roma, Italy N01BB03 Local anesthetic for injection
Naropina 10mg/ml injectable solution AstraZeneca, Milano, Italy N01BB09 Local anesthetic for injection
Oftasteril 5% eye drops Alfa Intes, Napoli, Italy S01AX18 5% povidone-iodine eye drops
EyeOP1 Eye Tech Care, Rillieux-la-Pape, France UCP device
BSS (balanced salt solution) Alcon Inc., Forth Worth, TX, USA 0065-1795-04 Sterile irrigating solution
Tobradex eye drops Alcon Italia Spa, Milano, Italy S01CA01 Antibiotic and steroid eye drops

Referanslar

  1. Congdon, N., et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122 (4), 477-485 (2004).
  2. Floriani, I., et al. Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational study. Acta Ophthalmol. , (2015).
  3. Traverso, C. E., et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol. 89 (10), 1245-1249 (2005).
  4. European Glaucoma Society. Terminology and guidelines for glaucoma. EGS Guidelines. , (2014).
  5. De Roetth, A. Cryosurgery for the treatment of glaucoma. Trans Am Ophthalmol Soc. 63, 189-204 (1965).
  6. Maus, M., Katz, L. J. Choroidal detachment, flat anterior chamber, and hypotony as complications of neodymium: YAG laser cyclophotocoagulation. Ophthalmology. 97 (1), 69-72 (1990).
  7. Uram, M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology. 99 (12), 1823-1828 (1992).
  8. al-Ghamdi, S., al-Obeidan, S., Tomey, K. F., al-Jadaan, I. Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes. Ophthalmic Surg. 24 (8), 526-529 (1993).
  9. Kosoko, O., Gaasterland, D. E., Pollack, I. P., Enger, C. L. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. 103 (8), 1294-1302 (1996).
  10. Hamard, P., Gayraud, J. M., Kopel, J., Valtot, F., Quesnot, S., Hamard, H. Treatment of refractory glaucomas by transscleral cyclophotocoagulation using semiconductor diode laser. Analysis of 50 patients followed-up over 19 months. J Fr Ophthalmol. 20 (2), 125-133 (1997).
  11. Sabri, K., Vernon, S. A. Scleral perforation following trans-scleral cyclodiode. Br J Ophthalmol. 83 (4), 502-503 (1999).
  12. Vernon, S. A., Koppens, J. M., Menon, G. J., Negi, A. K. Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. Clin Experiment Ophthalmol. 34 (5), 411-420 (2006).
  13. Aptel, F., Charrel, T., Palazzi, X., Chapelon, J. Y., Denis, P., Lafon, C. Histologic effects of a new device for high-intensity focused ultrasound cyclocoagulation. Invest Ophthalmol Vis Sci. 51 (10), 5092-5098 (2010).
  14. Aptel, F., et al. Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study. Invest Ophthalmol Vis Sci. 52 (12), 8747-8753 (2011).
  15. Aptel, F., Dupuy, C., Rouland, J. F. Treatment of refractory open-angle glaucoma using ultrasonic circular cyclocoagulation: a prospective case series. Curr Med Res Opin. 30 (8), 1599-1605 (2014).
  16. Aptel, F., et al. Short- and long-term effects on the ciliary body and the aqueous outflow pathways of high-intensity focused ultrasound cyclocoagulation. Ultrasound Med Biol. 40 (9), 2096-2106 (2014).
  17. Charrel, T., et al. Development of a miniaturized HIFU device for glaucoma treatment with conformal coagulation of the ciliary bodies. Ultrasound Med Biol. 37 (5), 742-754 (2011).
  18. Aptel, F., Lafon, C. Therapeutic applications of ultrasound in ophthalmology. Int J Hyperthermia. 28 (4), 405-418 (2012).
  19. Denis, P., et al. Cyclocoagulation of the ciliary bodies by high-intensity focused ultrasound: a 12-month multicenter study. Invest Ophthalmol Vis Sci. 56 (2), 1089-1096 (2015).
  20. Aptel, F., Lafon, C. Treatment of glaucoma with high intensity focused ultrasound. Int J Hyperthermia. 31 (3), 292-301 (2015).
  21. Giannaccare, G., et al. High-intensity focused ultrasound treatment in patients with refractory glaucoma. Graefes Arch Clin Exp Ophthalmol. 255 (3), 599-605 (2017).
  22. Mastropasqua, R., et al. Uveo-scleral outflow pathways after ultrasonic cyclocoagulation in refractory glaucoma: an anterior segment optical coherence tomography and in vivo confocal study. Br J Ophthalmol. 100 (12), 1668-1675 (2016).
  23. Melamed, S., Goldenfeld, M., Cotlear, D., Skaat, A., Moroz, I. High-intensity focused ultrasound treatment in refractory glaucoma patients: results at 1 year of prospective clinical study. Eur J Ophthalmol. 25 (6), 483-489 (2015).
  24. Aptel, F., Denis, P., Rouland, J. F., Renard, J. P., Bron, A. Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery. Acta Ophthalmol. 94 (5), e268-e277 (2016).
  25. Coleman, D. J., et al. Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology. 92 (3), 347-353 (1985).
  26. Valtot, F., Kopel, J., Haut, J. Treatment of glaucoma with high intensity focused ultrasound. Int Ophthalmol. 13 (1-2), 167-170 (1989).
  27. Burgess, S. E., et al. Treatment of glaucoma with high-intensity focused ultrasound. Ophthalmology. 93 (6), 831-838 (1986).
  28. Chen, J., Cohn, R. A., Lin, S. C., Cortes, A. E., Alvarado, J. A. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol. 124 (6), 787-796 (1997).
  29. Iliev, M. E., Gerber, S. Long-term outcome of trans-scleral diode laser cyclo-photocoagulation in refractory glaucoma. Br J Ophthalmol. 91 (12), 1631-1635 (2007).

Play Video

Bu Makaleden Alıntı Yapın
Giannaccare, G., Sebastiani, S., Campos, E. C. Ultrasound Cyclo Plasty in Eyes with Glaucoma. J. Vis. Exp. (131), e56192, doi:10.3791/56192 (2018).

View Video